Elevance Health — Oct 21, 2025 release

nue of $50.1 billion, up 12.0% from 3Q 2024   •   3Q 2025 diluted EPS 1 of $5.32; adjusted diluted EPS 2 of $6.03   •   Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively   •   Returned $3.3 billion of capital to shareholders year-to-date Indianapolis, IN - October 21, 2025 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. “Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we’re focused on advancing affordability and elevating the member experience through our growing value-based care partnerships and AI-enabled digital solutions that simplify access and improve outcomes. As we plan for 2026, we remain disciplined in managing what we can control – positioning our businesses for long-term, sustainable growth and value creation for all stakeholders.” Gail K. Boudreaux President and Chief Executive Officer     1. Earnings per diluted share (“EPS”).   2. Refer to GAAP reconciliation tables on pages 13 and 14 herein for reconciliation of GAAP to adjusted measures.   1       Elevance Health Consolidated Enterprise Highlights (Unaudited)           (In billions)   Three Months E